Conference abstract · 12 Sep 2016
Conference abstractPublished 1 Oct 2012
Myogenic differentiation of FSHD patient specific induced pluripotent stem cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
H uman induced pluripotent stem (IPS) cells overcome several disadvantages of human embryonic stem cells, including host specificity and ethical issues. Patient-specific IPS cells can be generated from every donor by using different cell types, making them a suitable tool for autologous cell therapy and tissue engineering. IPS cells generated from patients with genetic disorders capture the disease genotype in the cell, making them a good model for studying the pathology of the disease, especially during development, and testing different therapeutic approaches. FSHD is one of the most common inherited myopathies, caused by a contraction within a subtelomeric array of D4Z4 repeats 4q35.2. It is characterized by uneven and progressive weakness and atrophy of facial, shoulder and upper arm muscles. The D4Z4 repeat contains an intronless double homeobox gene named DUX4 (double homeobox, chromosome 4) which was recently shown to be expressed specifically in FSHD myoblasts, but not in unaffected control cells. DUX4 expressed in high levels induced rapid cell death and in the low levels interferes with myogenesis by missregulating MoyD and Myf5. Myoblasts expressing DUX4 failed to fuse and form terminally differentiated myotubes. We generated IPS from myoblasts and fibroblast from seven FSHD patients and five controls using four reprogramming factors, Sox2, Klf4, Oct4 and c-Myc. IPS cells were characterized by analyzing expression of pluripotent markers and formation of teratomas. From IPS cells we generated mesenchymal stem cells using EB culturing system and mesoderm inducing growth factors. Mesenchymal stem cells express specific surface markers including CD73 and CD105, and under specific condition were able for adipogenic and osteogenic differentiation. To induce myogenesis IPS-MSC we transfected with Myod or Myf5. Stably transfected cells were able to expand as myoblasts in myogenic proliferation medium. Generated myoblasts express specific marker CD56 and under differentiation condition in growth factor deprived medium were able to fuse and terminally differentiate in myotubes. Myoblasts generated from IPS cells transplanted in MDX mice were able to engraft and restore dystrofine expression.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 12 Sep 2016
Cardiomyocyte differentiation of human induced pluripotent stem cells: Modification of signaling pathways
Conference abstract · 12 Sep 2016
The effect of hypoxia on erythroid differentiation of human induced pluripotent stem cells
Conference abstract · 12 Sep 2016
Thermo-responsible copolymer interaction with human induced pluripotent stem cells for functional and pyramidal neuron differentiation
Conference abstract · 24 Sep 2014
Hepatic differentiation of human induced pluripotent stem cells in a perfused 3d porous polymer scaffold for liver tissue engineering
More from this journal
The newest in Journal of Tissue Science and Engineering.
Brief report · 29 Dec 2025
Skin Tissue Engineering: Accelerating Wound Healing With Biomaterials
Opinion · 29 Dec 2025
Biomaterials, Cells, And Stimulation For Spinal Cord Repair
Brief report · 29 Dec 2025
Cardiac Tissue Engineering: Building a New Heart
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Tissue Science and Engineering
- SubjectEngineering
- BylineArticles whose byline prints “Darko Bosnakovski”

